Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,849 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04641078 | Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer(DART) | unknown | Phase 2 | 124 | University Hospital, GhentOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04732156 | Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System(CHANGE) | unknown | N/A | 420 | Hospices Civils de LyonOTHER |
| 1 |
| Feb 28, 2024 |
| clinicaltrials |
| NCT05627752 | Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage | unknown | Phase 2 / Phase 3 | 120 | Zhongnan HospitalOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06031493 | A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Treated for Cervical Cancer (PROVIDENCE)(PROVIDENCE) | unknown | Phase 4 | 122 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06032910 | Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias | unknown | N/A | 25 | Charles University, Czech RepublicOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06231329 | Role of Elastography in Diagnosis of Testicular Tumors | unknown | — | 50 | Ali Mohamed Alaa El-dinOTHER | 0 | Feb 28, 2024 | clinicaltrials |
| NCT06274684 | Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia. | unknown | N/A | 100 | University Hospital, GenevaOTHER | 0 | Feb 28, 2024 | clinicaltrials |
| NCT06279832 | Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.(Romantic) | unknown | N/A | 1,000 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06281860 | Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration(PITHAC) | unknown | Phase 1 | 39 | Dr Jean Yannis PERENTESOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04492293 | An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer | unknown | Phase 2 | 115 | Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06258486 | Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks | unknown | Phase 4 | 100 | Kaiser PermanenteOTHER | 0 | Feb 26, 2024 | clinicaltrials |
| NCT06277947 | Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward(GARD-HIPEC) | unknown | N/A | 92 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06278636 | Laparoscopic Ultrasound Examination: Analysis of Feasibility(LUXA) | unknown | — | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04567719 | Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer | unknown | — | 9 | University of Kansas Medical CenterOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05701735 | Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer(CECIL) | unknown | N/A | 45 | University of Santo Tomas Hospital, PhilippinesOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05728814 | DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer(DORA) | unknown | — | 100 | Grupo Español de Investigación en Cáncer de OvarioOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06124040 | Sexual Function, Coping and Dyadic Coping in Patients With Cervical Cancer(SUCCEEDER) | unknown | — | 154 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06273878 | From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy | unknown | — | 80 | Regina Elena Cancer InstituteOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05279287 | Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS)(VAMIS) | unknown | — | 100 | The Griffin InstituteOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT05737797 | Non-Invasive Diagnosis of Endometrial Cancer(NIECE) | unknown | N/A | 100 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT06273501 | MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer(POSVUC) | unknown | N/A | 20 | Sahlgrenska University HospitalOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT02077335 | Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer | unknown | Phase 2 | 50 | CSSS de GatineauOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT05297552 | A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 40 | RemeGen Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06251492 | Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06253091 | Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy | unknown | N/A | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06148220 | A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors | unknown | N/A | 20 | Huashan HospitalOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06263062 | Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study | unknown | N/A | 60 | Alanya Alaaddin Keykubat UniversityOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06261879 | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood | unknown | N/A | 300 | WomenX Biotech LimitedINDUSTRY | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06261892 | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine | unknown | N/A | 300 | WomenX Biotech LimitedINDUSTRY | 1 | Feb 15, 2024 | clinicaltrials |
| NCT04145388 | Family History Study on Cancer Risk | unknown | N/A | 18,623 | Kaiser PermanenteOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT02730923 | Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)(VICTORIA) | unknown | Phase 1 / Phase 2 | 72 | Centre Leon BerardOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT05829057 | The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 | unknown | Phase 1 | 10 | Zhejiang UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT05587192 | Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model(RPWPB) | unknown | N/A | 57 | Anhui Provincial HospitalOTHER_GOV | 1 | Feb 12, 2024 | clinicaltrials |
| NCT06250686 | Exercise and Nutrition Intervention in Ovarian Cancer(BENITA) | unknown | N/A | 185 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT02820506 | Sentinel Node Mapping in Women With Endometrial and Cervical Cancer(SENTIREC II) | unknown | N/A | 300 | University of Southern DenmarkOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT03899077 | Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP(SAVE) | unknown | Phase 2 | 202 | Cancer Research AntwerpOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04149691 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | unknown | Phase 1 | 42 | Celon Pharma SAINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06069648 | Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening | unknown | N/A | 270 | Chinese University of Hong KongOTHER | 0 | Feb 7, 2024 | clinicaltrials |
| NCT06245759 | The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients | unknown | — | 120,000 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05189028 | Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer | unknown | Phase 3 | 290 | Chuangzhen ChenOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06243185 | Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors | unknown | Phase 2 | 30 | Fengzhi FengOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05947188 | Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC)(CMNDPC) | unknown | N/A | 808 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT06241105 | Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer | unknown | Phase 2 | 69 | Peking Union Medical College HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT06242392 | The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer | unknown | — | 250 | Fujian Cancer HospitalOTHER_GOV | 0 | Feb 5, 2024 | clinicaltrials |
| NCT04599218 | MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer | unknown | N/A | 1,586 | Ardeshir RastinehadOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT04656678 | Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer | unknown | N/A | 200 | Northwell HealthOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT05787535 | HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor | unknown | Phase 1 | 17 | HRYZ Biotech Co.INDUSTRY | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06238284 | HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China | unknown | — | 300 | Chongqing University Cancer HospitalOTHER | 0 | Feb 2, 2024 | clinicaltrials |
| NCT05212779 | Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease | unknown | — | 45 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Feb 1, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Feb 28, 2024source: clinicaltrials